| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |